Trials / Completed
CompletedNCT02218801
A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 219 (actual)
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This prospective database has two main objectives; * to evaluate the complication rates, 30-day and 90-day mortality from different surgical strategies for unresectable, borderline resectable or initially unresectable liver metastasis from colorectal cancer. * to establish baseline quality parameters for different surgical strategies for unresectable, borderline and initially unresectable colorectal liver metastasis (CRLM) patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Evaluation of treatment for liver metastasis |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2020-01-01
- Completion
- 2021-02-01
- First posted
- 2014-08-18
- Last updated
- 2022-05-31
Locations
16 sites across 12 countries: Austria, Belgium, Denmark, France, Germany, Italy, Netherlands, Serbia, Spain, Sweden, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT02218801. Inclusion in this directory is not an endorsement.